{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:02:57Z","timestamp":1791644577033,"version":"4.3.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,15]]},"DOI":"10.1093\/infdis\/jis497","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T05:44:48Z","timestamp":1344404688000},"page":"1280-1290","source":"Crossref","is-referenced-by-count":149,"title":["A Phase 1\/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults"],"prefix":"10.1093","volume":"206","author":[{"given":"Isabel","family":"Leroux-Roels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vandepapeli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ventzislav","family":"Vassilev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Ledent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Heineman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,7]]},"reference":[{"issue":"Suppl 1","key":"key\n\t\t\t\t20170522114543_JIS497C1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","article-title":"Advances in the understanding of the pathogenesis and epidemiology of herpes zoster","volume":"48","author":"Gershon","year":"2010","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20170522114543_JIS497C2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.30","article-title":"Herpes zoster and postherpetic neuralgia","volume":"9","author":"Johnson","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170522114543_JIS497C3","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","article-title":"Vaccination against herpes zoster and postherpetic neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4065\/mcp.2010.0618","article-title":"Herpes zoster recurrences more frequent than previously reported","volume":"86","author":"Yawn","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20170522114543_JIS497C5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/653605","article-title":"Zoster vaccine: current status and future prospects","volume":"51","author":"Oxman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C6","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.vaccine.2011.04.019","article-title":"Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection","volume":"29","author":"Oxman","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522114543_JIS497C7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/erv.09.12","article-title":"Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response","volume":"8","author":"McElhaney","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170522114543_JIS497C8","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S1386-6532(10)70004-4","article-title":"Prevention strategies for herpes zoster and post-herpetic neuralgia","volume":"48","author":"Levin","year":"2010","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20170522114543_JIS497C9","first-page":"S18","article-title":"Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination","volume":"109","author":"Gelb","year":"2009","journal-title":"J Am Osteopath Assoc"},{"key":"key\n\t\t\t\t20170522114543_JIS497C10","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522114543_JIS497C11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522114543_JIS497C12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C13","first-page":"153","article-title":"Recombinant subunit vaccines: potentials and constraints","volume":"121","author":"Clark","year":"2005","journal-title":"Dev Biol (Basel)"},{"key":"key\n\t\t\t\t20170522114543_JIS497C14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4049\/jimmunol.137.4.1346","article-title":"Immunity to varicella-zoster viral glycoproteins, gp I (gp 90\/58) and gp III (gp 118), and to a nonglycosylated protein, p 170","volume":"137","author":"Arvin","year":"1986","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522114543_JIS497C15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/infdis\/156.3.430","article-title":"Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response","volume":"156","author":"Brunell","year":"1987","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.mi.44.100190.000423","article-title":"Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking","volume":"44","author":"Grose","year":"1990","journal-title":"Annu Rev Microbiol"},{"key":"key\n\t\t\t\t20170522114543_JIS497C17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jmv.1890300114","article-title":"Antibody responses in recipients of varicella vaccine assayed by immunoblotting","volume":"30","author":"Harper","year":"1990","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170522114543_JIS497C18","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0264-410X(01)00486-8","article-title":"Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation","volume":"20","author":"Jacquet","year":"2002","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522114543_JIS497C19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","article-title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","volume":"6","author":"Garcon","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170522114543_JIS497C20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.vaccine.2007.12.038","article-title":"Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers","volume":"26","author":"Vandepapeliere","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522114543_JIS497C21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20170522114543_JIS497C22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C23","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1016\/j.vaccine.2010.08.035","article-title":"Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef, and Tat antigens formulated in three Adjuvant Systems","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522114543_JIS497C24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-1702(95)01270-2","article-title":"Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells","volume":"40","author":"Haumont","year":"1996","journal-title":"Virus Res"},{"key":"key\n\t\t\t\t20170522114543_JIS497C25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10875-010-9490-6","article-title":"H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses","volume":"31","author":"Moris","year":"2011","journal-title":"J Clin Immunol"},{"key":"key\n\t\t\t\t20170522114543_JIS497C26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/315347","article-title":"Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression","volume":"181","author":"Asanuma","year":"2000","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C27","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/605611","article-title":"Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine","volume":"200","author":"Weinberg","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.vaccine.2011.11.096","article-title":"Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults \u226560 years of age","volume":"30","author":"Vermeulen","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522114543_JIS497C29","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0264-410X(99)00510-1","article-title":"Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial","volume":"18","author":"Trannoy","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522114543_JIS497C30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1473-3099(11)70100-1","article-title":"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial","volume":"11","author":"Asante","year":"2011","journal-title":"Lancet ID"},{"key":"key\n\t\t\t\t20170522114543_JIS497C31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/cid\/ciq160","article-title":"An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers","volume":"52","author":"Van Braeckel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522114543_JIS497C32","article-title":"Improved CD4(+) T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: A randomized trial","volume":"[Epub ahead of print]","author":"Leroux-Roels","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522114543_JIS497C33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/206\/8\/1280\/17409054\/jis497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T06:10:37Z","timestamp":1687673437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jis497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,7]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,8,7]]},"published-print":{"date-parts":[[2012,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jis497","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,7]]}}}